K4 Elite logo K4 Elite
Home / Peptide Library / Thymalin
Well Researched

Thymalin

Inflammation & Immunity · ['Thymalin', 'Thymus polypeptide fraction', 'Thymic peptide complex']

Thymalin is a polypeptide complex extracted from the thymus gland, studied for immunomodulatory activity and for its influence on T-cell populations. It has been examined in Russian clinical and gerontological research and is offered strictly for laboratory research.

🔬 Research use only — not for human or veterinary use. K4 Elite does not provide dosing instructions.
Molecular Formula
C33H54N12O15
Molecular Weight
858.9 g/mol
PubChem
CID 3085284 ↗
Research Level
Well Researched
Browse the store →
Thymalin chemical structure

Thymalin is a peptide preparation obtained from the thymus gland, developed within the same St. Petersburg bioregulation research tradition associated with thymic peptides such as thymosin and thymopoietin fragments. It is described as a complex of low-molecular-weight polypeptides rather than a single defined molecule; the PubChem entry listed reflects a representative associated structure.

Thymalin has been studied primarily in Russian clinical and experimental literature for immunomodulatory activity, particularly effects on T-lymphocyte populations and cell-mediated immunity, and in gerontological studies of aging populations.

Content here summarizes the available literature. Thymalin is intended for research use only and is not an approved drug or supplement in this context.

Thymalin is reported to modulate the differentiation and function of T-lymphocytes, influencing the balance of T-cell subpopulations and indices of cell-mediated immunity. It is described as helping restore immune indices toward normal ranges in models of immune dysregulation.

Because it is a polypeptide complex, its mechanism is characterized at the level of immunological outcomes rather than a single defined receptor interaction. Much of the mechanistic and clinical characterization appears in Russian-language gerontology and immunology literature.

  • T-cell immunomodulation: Studied for effects on T-lymphocyte differentiation and cell-mediated immune indices (Khavinson and colleagues).
  • Gerontology / aging: Examined in long-term studies of elderly cohorts for effects on immune and physiological aging markers (Khavinson & Morozov, 2003).
  • Immune restoration in disease models: Investigated in contexts of secondary immunodeficiency and infection recovery.
  • Neuroendocrine-immune interaction: Studied within the broader peptide-bioregulation framework linking thymic peptides to homeostatic regulation.
  • Radioprotection / stress models: Examined in experimental settings involving immune suppression.
📋 How published studies were conducted — a research reference summarizing study designs from the literature. This is not usage, dosing, or administration guidance. K4 Elite does not provide dosing instructions; determining any research protocol is the sole responsibility of the qualified researcher.

Reporting only — not guidance. Khavinson and Morozov (2003, Neuroendocrinol Lett) reported results of long-term clinical observations in which thymic peptide preparations including thymalin were administered to elderly subjects, describing effects on immune indices and mortality-related outcomes over multi-year follow-up.

Additional experimental studies in the peptide-bioregulation literature describe administration of thymalin in animal and clinical models of immune dysregulation, reporting normalization of T-cell subpopulation indices. These summaries describe published studies and are provided for reporting only, not as protocols for use.

Combinations examined in the research literature. Descriptive only — not a recommendation to combine compounds.

Thymosin alpha-1Compatible
Related thymic immunomodulatory peptide studied in overlapping contexts.
Epithalamin / EpitalonSynergistic
Studied together in Khavinson gerontology research on aging.
Immunosuppressive agentsCaution
Opposing effects on immune function; combined effects uncharacterized.
Vaccine / infection modelsNeutral
Studied as immune modulator in research settings; no established co-use data.
  1. Khavinson VKh, Morozov VG. Peptides of pineal gland and thymus prolong human life. Neuroendocrinol Lett 2003
  2. Khavinson VKh. Peptides and Ageing. Neuroendocrinol Lett 2002 (review)
  3. Thymalin — PubChem Compound Summary, CID 3085284
Is thymalin approved as a therapy?
In this reference thymalin is treated as a research compound for laboratory use only. Its clinical use appears chiefly in Russian literature and it is not a broadly approved drug or supplement here.
What is thymalin made of?
It is a complex of low-molecular-weight polypeptides extracted from the thymus gland, not a single defined molecule.
What is it studied for?
Published research focuses on immunomodulation, particularly T-lymphocyte populations and cell-mediated immunity, and on gerontological outcomes in aging cohorts.
How does it differ from thymosin alpha-1?
Thymosin alpha-1 is a single defined 28-amino-acid peptide, whereas thymalin is a polypeptide complex. Both derive from thymic tissue and are studied for immune modulation.
Can you tell me how much to use?
No. This reference provides research context only and does not include human or veterinary dosing, routes, or administration guidance.
Disclaimer: This profile summarizes published preclinical and laboratory research for reference only. It is not medical advice and makes no claim of safety or efficacy in humans. Determining any research protocol is the sole responsibility of the qualified researcher. Products are sold strictly for in-vitro research and have not been evaluated by the FDA.